Dermatology · Elmhurst, NY
NPI
1235167313
Since 2006
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
8516 Queens Blvd Fl 1
Elmhurst, NY, 11373
Phone (718) 457-0002
Groups this clinician bills Medicare through
Medicare paid, 2024
$85K
1,240 services
Medicare patients, 2024
333
Average age 77
Drug cost, 2024
$10.3M
18,035 prescriptions
Company payments, 2025
$38K
From 20 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Huachen Wei was code 99213 (office e&m - established), 380 times for 207 patients. In total Huachen Wei billed 1,240 services in 25 codes, and Medicare paid $85K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-08-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 380 | 207 | $70.59 | $27K |
| 99203 Office E&M - New | Office | 149 | 149 | $83.12 | $12K |
| 99212 Office E&M - Established | Office | 108 | 77 | $46.00 | $4,968 |
| 17110 Destruction Skin Lesion | Office | 87 | 48 | $88.59 | $7,708 |
| 17111 Destruction Skin Lesion | Office | 82 | 49 | $102.01 | $8,365 |
| 11102 Skin Biopsy | Office | 64 | 59 | $84.29 | $5,395 |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 63 | 24 | $0.72 | $45.11 |
| 11901 Skin | Office | 38 | 14 | $59.06 | $2,244 |
| 11103 Skin Biopsy | Office | 37 | 23 | $43.44 | $1,607 |
| 67850 Eye | Office | 36 | 19 | $147.06 | $5,294 |
| 11900 Skin | Office | 26 | 13 | $42.66 | $1,109 |
| 10061 Skin | Office | 19 | 15 | $186.83 | $3,550 |
By year: 2022 $69K for 941 services; 2023 $91K for 1,201 services; 2024 $85K for 1,240 services.
Medicare prescription drug claims, 2024
In 2024, the drug Huachen Wei prescribed most often to Medicare patients was Ketoconazole, with 1,907 prescriptions and refills. In total Huachen Wei wrote 18,035 Medicare prescriptions that cost $10.3M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ketoconazole Generic | 1,907 | 1,963 | 654 | $30K |
| Mupirocin Generic | 1,733 | 1,735 | 1,394 | $13K |
| Ammonium Lactate Generic | 1,701 | 1,763 | 811 | $47K |
| Clobetasol Propionate Generic | 1,342 | 1,354 | 668 | $87K |
| Triamcinolone Acetonide Generic | 1,138 | 1,163 | 774 | $19K |
| Mometasone Furoate Generic | 1,112 | 1,116 | 817 | $21K |
| Halobetasol Propionate Generic | 1,042 | 1,047 | 764 | $73K |
| Ciclopirox Ciclopirox Olamine | 842 | 865 | 476 | $33K |
| Fluocinonide Generic | 781 | 782 | 480 | $40K |
| Hydrocortisone Generic | 668 | 670 | 506 | $7,901 |
| Dupixent Syringe Dupilumab | 386 | 390 | 69 | $1.5M |
| Prednisone Generic | 374 | 397 | 285 | $1,378 |
| Lidocaine-Prilocaine Lidocaine/Prilocaine | 370 | 379 | 304 | $4,329 |
| Tacrolimus Generic | 363 | 369 | 168 | $74K |
| Metronidazole Generic | 321 | 323 | 148 | $21K |
Brand drugs: 1,786 claims; generic drugs: 16,218 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Huachen Wei $38K ($38K in general payments such as food, travel and fees) from 20 companies. The largest payer was Janssen Biotech, Inc. with $19K.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 45 | $19K |
| Abbvie Inc. ABBV | 35 | $17K |
| Arcutis Biotherapeutics, Inc. ARQT | 24 | $300 |
| Novartis Pharmaceuticals Corporation NVS | 13 | $235 |
| Incyte Corporation INCY | 12 | $219 |
| Organon LLC OGN | 10 | $204 |
| LEO Pharma Inc. | 14 | $198 |
| Pfizer Inc. PFE | 8 | $184 |
| Galderma Laboratories, L.P. GALD.SW | 12 | $183 |
| UCB, Inc. UCB.BR | 6 | $121 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.